Quick Links
Resources
About MyMSTeam
Powered By
Disease-modifying therapies (DMTs) can be effective treatment for multiple sclerosis (MS). These drugs are approved by the U.S. Food and Drug Administration (FDA) because of their proven ability to slow disease progress in people with MS. But for people with relapsing MS, it’s common to switch DMTs over the course of the disease.
In a large study spanning around 20 years, researchers followed 110,326 people diagnosed with relapsing-remitting MS (RRMS). The study found that participants switched DMTs 159,309 times within six months of starting a new drug.
There are several reasons you and your neurologist may decide to switch your MS treatment from one DMT to another, including bothersome side effects and continued MS relapses (also known as flares) and disease progression. Additionally, medications sometimes become less effective over time.
MS is an autoimmune disease in which the immune system mistakenly attacks the myelin sheath that covers nerves. DMTs don’t treat MS symptoms, but they work by blocking parts of the immune system that damage the central nervous system (CNS, or brain and spinal cord). Research shows that early and continued use of DMTs for MS can reduce the rate of MS flares, lessen inflammation in the CNS, and delay disability progression.
More than 25 DMTs have been approved by the FDA for the treatment of MS, and more new DMTs are in development. Some DMTs are taken orally, and others are taken by subcutaneous (under the skin) injection or by intravenous (IV) infusion. Injected drugs can either be self-injected at home or given in a clinical setting. Infused drugs must be administered by a health care provider.
A few of the DMTs approved to treat MS include:
If switching disease-modifying treatments is appropriate for you, your neurologist will provide detailed information about different DMTs, potential side effects, and how they are taken. That way, you can make an informed decision based on your treatment goals and preferences.
Read more about specific medications in this list of treatments for multiple sclerosis.
According to neurology research, one reason DMTs stop working effectively is that a person’s body may eventually develop antibodies (immune proteins) against these drugs. Normally, your immune system produces antibodies to fight foreign invaders such as bacteria and viruses.
When you take MS medication, your immune system may gradually recognize the drug as a foreign substance and make antibodies against it, preventing it from working properly. People taking interferons or alemtuzumab (Lemtrada) have a higher risk of developing these types of antibodies.
Before considering a treatment switch, doctors usually wait until enough time has passed to allow a DMT to fully take effect — on average, at least one year. That’s usually long enough to monitor the response to a new treatment with magnetic resonance imaging (MRI) and watch for worsening symptoms. It’s important to maintain your treatment plan and continue taking your current medication exactly as directed to make sure it works as effectively as possible.
On average, it takes one year for a DMT to fully take effect. Only at that point can your neurologist determine whether or not it is working well for you.
Neurologists treating MS will look for signs that indicate it may be advisable to consider switching DMTs, including one of the following reasons.
Despite following your DMT treatment plan as directed, you may still experience signs of breakthrough disease, including:
Any of these factors may be signs it’s time to consider different treatment options.
If you continue to experience relapses, have worsening symptoms, or develop new brain lesions despite taking a DMT as directed, your doctor may recommend switching.
Because DMTs suppress the immune system, they increase the risk of infections. For some people, that may be a reason to discontinue a particular medication. The good news is that DMTs are becoming safer, and the incidence of infections is lower with newer DMTs.
Progressive multifocal leukoencephalopathy (PML) is a rare, but serious, brain infection associated with some DMTs. PML can cause disability or even death. PML is very uncommon, even among people taking DMTs, but all FDA-approved MS treatments still include a black box warning about the risk. If you are taking a DMT, your doctor will monitor you for infections, including PML.
If a relapsing form of MS advances to progressive MS, it may be time to switch medications. Neurologists track disease progression and measure the effectiveness of DMTs with tools such as the Expanded Disability Status Scale (EDSS) and assessments of quality of life in comparison to your baseline (original) symptoms.
If your MS progresses or transitions to progressive MS, it may be a sign that your current DMT is not effective enough.
Your doctor may recommend tests such as MRI scans of the CNS to look for enlarging or new lesions. MS activity that’s visible on MRI scans usually indicates MS disease progression.
Most people with MS are initially diagnosed with relapsing multiple sclerosis, which is characterized by symptom flare-ups followed by periods of relative recovery. People with RRMS often progress to SPMS, in which symptoms and disability gradually worsen. Progression to SPMS early in your disease course can be a sign that your current treatment may not be effective.
Making treatment decisions can be stressful, but open communication can help ensure you meet your treatment goals. Through shared decision-making, your doctor’s recommendations and your concerns are discussed in detail in order to find a treatment option that best fits your lifestyle and needs. Shared decision-making has been shown to improve the health outcomes of people living with MS.
Make sure you regularly follow up with your neurologist and attend any scheduled appointments. Your doctors need to see how your MS is progressing in order to determine if your current DMT is working effectively.
No one knows your MS symptoms better than you. Always let your health care providers know about any new or worsening symptoms.
If you’re considering switching MS treatments, read about washout periods — time between stopping one treatment and beginning another — and when they may be needed.
MyMSTeam is the social network for people with multiple sclerosis and their loved ones. On MyMSTeam, more than 211,000 members come together to ask questions, give advice, and share their stories with others who understand life with MS.
Do you have questions about switching medications for MS? Have you and your doctor discussed a treatment change? Share your questions and experiences in the comments below, or start a conversation on your Activities page.
Get updates directly to your inbox.
Rebif 22mcg And Low WBC At 2.6
Sign up for free!
Become a member to get even more
Your privacy is our priority.
A MyMSTeam Member
If MRI shows no new lesions/ reduction in size of existing lesions, is that an indication to stop, or continue the DMT?
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.